Samantha Mascelli Selected Research

Glioma (Gliomas)

1/2020	Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition.
7/2019	Advanced MR imaging and 18F-DOPA PET characteristics of H3K27M-mutant and wild-type pediatric diffuse midline gliomas.
12/2015	Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.
3/2015	Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019.
9/2012	Analysis of NADP+-dependent isocitrate dehydrogenase-1/2 gene mutations in pediatric brain tumors: report of a secondary anaplastic astrocytoma carrying the IDH1 mutation.
9/2012	Characterization of glioma stem cells through multiple stem cell markers and their specific sensitization to double-strand break-inducing agents by pharmacological inhibition of ataxia telangiectasia mutated protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Samantha Mascelli Research Topics

Disease

13	Neoplasms (Cancer) 01/2020 - 06/2010
6	Glioma (Gliomas) 01/2020 - 09/2012
3	Glioblastoma (Glioblastoma Multiforme) 03/2015 - 09/2012
2	Astrocytoma (Pilocytic Astrocytoma) 01/2016 - 09/2012
2	Brain Neoplasms (Brain Tumor) 12/2015 - 09/2012
2	Ataxia Telangiectasia (Louis Bar Syndrome) 07/2014 - 09/2012
2	Neoplasm Metastasis (Metastasis) 01/2014 - 06/2010
1	Chordoma 01/2017
1	Rhabdoid Tumor (Rhabdoid Tumors) 09/2014
1	Typical Teratoid Rhabdoid Tumor 09/2014
1	Craniopharyngioma (Craniopharyngiomas) 09/2012
1	Spinal Dysraphism (Spina Bifida) 07/2011
1	Medulloblastoma 05/2011
1	Craniosynostoses (Craniosynostosis) 01/2009
1	Neural Tube Defects (Exencephaly) 01/2006

Drug/Important Bio-Agent (IBA)

5	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 01/2009
3	Dihydroxyphenylalanine (Dopa)IBA 07/2019 - 12/2015
2	CreatineIBA 07/2019 - 12/2015
2	Lactic Acid (Lactate)FDA LinkGeneric 07/2019 - 12/2015
2	Choline (Choline Chloride)IBA 07/2019 - 12/2015
2	N-acetylaspartate (N-acetyl aspartate)IBA 07/2019 - 12/2015
2	Biological ProductsIBA 09/2017 - 09/2014
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 09/2012
2	Codon (Codons)IBA 01/2016 - 09/2012
2	2- (2,6- dimethylmorpholin- 4- yl)- N- (5- (6- morpholin- 4- yl- 4- oxo- 4H- pyran- 2- yl)- 9H- thioxanthen- 2- yl)acetamideIBA 03/2015 - 07/2014
2	Ataxia Telangiectasia Mutated ProteinsIBA 07/2014 - 09/2012
2	Folic Acid (Vitamin M)FDA LinkGeneric 07/2011 - 01/2006
1	Nonsense Codon (Nonsense Mutation)IBA 01/2017
1	Brachyury protein (Brachyury)IBA 01/2017
1	arginylarginine (Arg-Arg)IBA 01/2016
1	fluorodopa F 18IBA 12/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2014
1	Pharmaceutical PreparationsIBA 07/2014
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 09/2012
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 09/2012
1	NADP (NADPH)IBA 09/2012
1	Arginine (L-Arginine)FDA Link 09/2012
1	isocitric acid (isocitrate)IBA 09/2012
1	Histidine (L-Histidine)FDA Link 09/2012
1	Caffeine (No Doz)FDA LinkGeneric 07/2011
1	HomocysteineIBA 07/2011
1	Messenger RNA (mRNA)IBA 05/2011
1	Coloring Agents (Dyes)IBA 05/2011
1	EnzymesIBA 01/2006
1	Methylenetetrahydrofolate Dehydrogenase (NADP) (Dehydrogenase, Methylenetetrahydrofolate)IBA 01/2006

Therapy/Procedure

1	Chemoradiotherapy 01/2020
1	Therapeutics 01/2020
1	Drug Therapy (Chemotherapy) 09/2014
1	Radiotherapy 09/2012
1	Caloric Restriction 07/2011